Similarly, the copy number values of POU4F1 had no difference between subtypes of breast cancer patients and cell lines (Figure S7B,C, Supporting Information), suggesting that genetic alteration, including gain‐of‐function mutation and copy number amplification, did not contributed to POU4F1 expression in BLBC. This evidence concerns the gene POU4F1 and breast carcinoma.